Correlation Between X4 Pharmaceuticals and Cyclo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Cyclo Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Cyclo Therapeutics.

Diversification Opportunities for X4 Pharmaceuticals and Cyclo Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between XFOR and Cyclo is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Cyclo Therapeutics go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Cyclo Therapeutics

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 6.8 times less return on investment than Cyclo Therapeutics. In addition to that, X4 Pharmaceuticals is 2.66 times more volatile than Cyclo Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Cyclo Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest  69.00  in Cyclo Therapeutics on November 9, 2024 and sell it today you would earn a total of  8.00  from holding Cyclo Therapeutics or generate 11.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Cyclo Therapeutics

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Cyclo Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Cyclo Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

X4 Pharmaceuticals and Cyclo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Cyclo Therapeutics

The main advantage of trading using opposite X4 Pharmaceuticals and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.
The idea behind X4 Pharmaceuticals and Cyclo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA